GABA A-positive modulator selective discriminative stimulus effects of 1,1,1-trichloroethane vapor

Drug and Alcohol Dependence

Volumn 121, Issue 1-2, 2012, Pages 103-109

  Shelton, Keith L ^a   Nicholson, Katherine L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

1,1,1 Trichloroethane; Drug discrimination; Inhalants; Solvents

Indexed keywords

1,1,1 TRICHLOROETHANE; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA1; 4 PHOSPHONOMETHYLPIPECOLIC ACID; 7 CHLORO 4 HYDROXY 3 (3 PHENOXYPHENYL) 2 QUINOLONE; ALCOHOL; DIAZEPAM; DIZOCILPINE; GABOXADOL; MIDAZOLAM; NITROUS OXIDE; PENTOBARBITAL; TIAGABINE; TILETAMINE PLUS ZOLAZEPAM; VALPROIC ACID; ZALEPLON; 1,1,1-TRICHLOROETHANE; ACETAMIDE DERIVATIVE; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; PYRIMIDINE DERIVATIVE; TRICHLOROETHANE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG ABUSE; MALE; MOUSE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; VAPOR; ANIMAL; DRUG EFFECT; PERCEPTIVE DISCRIMINATION;

MUS;

ACETAMIDES; ANIMALS; DIAZEPAM; DISCRIMINATION (PSYCHOLOGY); GABA MODULATORS; MALE; MICE; MIDAZOLAM; PENTOBARBITAL; PYRIMIDINES; TRICHLOROETHANES;

EID: 84855885765     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2011.08.016     Document Type: Article

References (49)

1. Ator N.A., Griffiths R.R. Selectivity in the generalization profile in baboons trained to discriminate lorazepam: benzodiazepines, barbiturates and other sedative/anxiolytics. J. Pharmacol. Exp. Ther. 1997, 282:1442-1457.
2. Bale A.S., Meacham C.A., Benignus V.A., Bushnell P.J., Shafer T.J. Volatile organic compounds inhibit human and rat neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes. Toxicol. Appl. Pharmacol. 2005, 205:77-88.
3. Balster R.L. Drug abuse potential evaluation in animals. Br. J. Addict. 1991, 86:1549-1558.
4. Beckstead M.J., Phelan R., Mihic S.J. Antagonism of inhalant and volatile anesthetic enhancement of glycine receptor function. J. Biol. Chem. 2001, 276:24959-24964.
5. Beckstead M.J., Phelan R., Trudell J.R., Bianchini M.J., Mihic S.J. Anesthetic and ethanol effects on spontaneously opening glycine receptor channels. J. Neurochem. 2002, 82:1343-1351.
6. Beckstead M.J., Weiner J.L., Eger E.I., Gong D.H., Mihic S.J. Glycine and gamma-aminobutyric acid(A) receptor function is enhanced by inhaled drugs of abuse. Mol. Pharmacol. 2000, 57:1199-1205.
7. Bennett D.A., Lehmann J., Bernard P.S., Liebman J.M., Williams M., Wood P.L., Boast C.A., Hutchison A.J. CGS 19755: a novel competitive N-methyl-d-aspartate (NMDA) receptor antagonist with anticonvulsant, anxiolytic and anti-ischemic properties. Prog. Clin. Biol. Res. 1990, 361:519-524.
8. Bobelis D.J., Balster R.L. Pharmacological specificity of the discriminative stimulus properties of 2-amino-4,5-(1,2-cyclohexyl)-7-phosphono-heptanoic acid (NPC 12626), a competitive N-methyl-d-aspartate receptor antagonist. J. Pharmacol. Exp. Ther. 1993, 264:845-853.
9. Bowen S.E., Balster R.L. Effects of inhaled 1,1,1-trichloroethane on locomotor activity in mice. Neurotoxicol. Teratol. 1996, 18:77-81.
10. Bowen S.E., Daniel J., Balster R.L. Deaths associated with inhalant abuse in Virginia from 1987 to 1996. Drug Alcohol Depend. 1999, 53:239-245.
11. Bowen S.E., Wiley J.L., Jones H.E., Balster R.L. Phencyclidine- and diazepam-like discriminative stimulus effects of inhalants in mice. Exp. Clin. Psychopharmacol. 1999, 7:28-37.
12. Chandra D., Jia F., Liang J., Peng Z., Suryanarayanan A., Werner D.F., Spigelman I., Houser C.R., Olsen R.W., Harrison N.L., Homanics G.E. GABAA receptor alpha 4 subunits mediate extrasynaptic inhibition in thalamus and dentate gyrus and the action of gaboxadol. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:15230-15235.
13. Colpaert F.C. Drug discrimination in neurobiology. Pharmacol. Biochem. Behav. 1999, 64:337-345.
14. Colquhoun D. Lectures on Biostatistics 1971, Clarendon Press, London.
15. Cruz S.L., Balster R.L., Woodward J.J. Effects of volatile solvents on recombinant N-methyl-d-aspartate receptors expressed in Xenopus oocytes. Br. J. Pharmacol. 2000, 131:1303-1308.
16. Flanagan R.J., Ruprah M., Meredith T.J., Ramsey J.D. An introduction to the clinical toxicology of volatile substances. Drug Saf. 1990, 5:359-383.
17. Grant K.A., Colombo G. Pharmacological analysis of the mixed discriminative stimulus effects of ethanol. Alcohol Alcohol. Suppl. 1993, 2:445-449.
18. Harris R.A., Mihic S.J., Brozowski S., Hadingham K., Whiting P.J. Ethanol, flunitrazepam, and pentobarbital modulation of GABAA receptors expressed in mammalian cells and Xenopus oocytes. Alcohol. Clin. Exp. Res. 1997, 21:444-451.
19. Herd M.B., Foister N., Chandra D., Peden D.R., Homanics G.E., Brown V.J., Balfour D.J., Lambert J.J., Belelli D. Inhibition of thalamic excitability by 4,5,6,7-tetrahydroisoxazolo[4,5-c]pyridine-3-ol: a selective role for delta-GABA(A) receptors. Eur. J. Neurosci. 2009, 29:1177-1187.
20. Johannessen C.U. Mechanisms of action of valproate: a commentatory. Neurochem. Int. 2000, 37:103-110.
21. Johnston L.D., O'Malley P.M., Bachman J.G. Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2010 2011, Institute for Social Research, The University of Michigan, Ann Arbor, p. 77.
22. Licata S.C., Platt D.M., Cook J.M., Sarma P., Griebel G., Rowlett J.K. Contribution of GABAA receptor subtypes to the anxiolytic-like, motor, and discriminative stimulus effects of benzodiazepines: studies with the functionally selective ligand SL651498 [6-fluoro-9-methyl-2-phenyl-4-(pyrrolidin-1-yl-carbonyl)-2,9-dihydro-1H-pyridol[3,4-b]indol-1-one]. J. Pharmacol. Exp. Ther. 2005, 313:1118-1125.
23. Lopreato G.F., Phelan R., Borghese C.M., Beckstead M.J., Mihic S.J. Inhaled drugs of abuse enhance serotonin-3 receptor function. Drug Alcohol Depend. 2003, 70:11-15.
24. MacIver M.B. Abused inhalants enhance GABA-mediated synaptic inhibition. Neuropsychopharmacology 2009, 34:2296-2304.
25. Michelsen S., Sanchez C., Ebert B. Lack of generalisation between the GABAA receptor agonist, gaboxadol, and allosteric modulators of the benzodiazepine binding site in the rat drug discrimination procedure. Psychopharmacology (Berl.) 2007, 193:151-157.
26. Nicholson K.L., Balster R.L. The discriminative stimulus effects of N-methyl-d-aspartate glycine-site ligands in NMDA antagonist-trained rats. Psychopharmacology (Berl.) 2009, 203:441-455.
27. Paez-Martinez N., Ambrosio E., Garcia-Lecumberri C., Rocha L., Montoya G.L., Cruz S.L. Toluene and TCE decrease binding to mu-opioid receptors, but not to benzodiazepine and NMDA receptors in mouse brain. Ann. N. Y. Acad. Sci. 2008, 1139:390-401.
28. Pistis M., Belelli D., Peters J.A., Lambert J.J. The interaction of general anaesthetics with recombinant GABAA and glycine receptors expressed in Xenopus laevis oocytes: a comparative study. Br. J. Pharmacol. 1997, 122:1707-1719.
29. Priestley T., Laughton P., Macaulay A.J., Hill R.G., Kemp J.A. Electrophysiological characterisation of the antagonist properties of two novel NMDA receptor glycine site antagonists, L-695,902 and L-701,324. Neuropharmacology 1996, 35:1573-1581.
30. Rahman M., Zhu D., Lindblad C., Johansson I.M., Holmberg E., Isaksson M., Taube M., Backstrom T., Wang M.D. GABA-site antagonism and pentobarbital actions do not depend on the alpha-subunit type in the recombinant rat GABA receptor. Acta. Physiol. (Oxf.) 2006, 187:479-488.
31. Rees D.C., Knisely J.S., Balster R.L., Jordan S., Breen T.J. Pentobarbital-like discriminative stimulus properties of halothane, 1,1,1-trichloroethane, isoamyl nitrite, flurothyl and oxazepam in mice. J. Pharmacol. Exp. Ther. 1987, 241:507-515.
32. Rees D.C., Knisely J.S., Breen T.J., Balster R.L. Toluene, halothane, 1,1,1-trichloroethane and oxazepam produce ethanol-like discriminative stimulus effects in mice. J. Pharmacol. Exp. Ther. 1987, 243:931-937.
33. Rowlett J.K., Lelas S., Spealman R.D. Transduction of the discriminative stimulus effects of zolpidem by GABA(A)/alpha1 receptors. Eur. J. Pharmacol. 2000, 406:R9-R10.
34. Saarelainen K.S., Ranna M., Rabe H., Sinkkonen S.T., Moykkynen T., Uusi-Oukari M., Linden A.M., Luddens H., Korpi E.R. Enhanced behavioral sensitivity to the competitive GABA agonist, gaboxadol, in transgenic mice over-expressing hippocampal extrasynaptic alpha6beta GABA(A) receptors. J. Neurochem. 2008, 105:338-350.
35. Sanger D.J. Substitution by NMDA antagonists and other drugs in rats trained to discriminate ethanol. Behav. Pharmacol. 1993, 4:523-528.
36. Savic M.M., Huang S., Furtmuller R., Clayton T., Huck S., Obradovic D.I., Ugresic N.D., Sieghart W., Bokonjic D.R., Cook J.M. Are GABAA receptors containing alpha5 subunits contributing to the sedative properties of benzodiazepine site agonists?. Neuropsychopharmacology 2008, 33:332-339.
37. Schuster C.R., Johanson C.E. Relationship between the discriminative stimulus properties and subjective effects of drugs. Psychopharmacol. Ser. 1988, 4:161-175.
38. Shannon H.E., Herling S. Discriminative stimulus effects of diazepam in rats: evidence for a maximal effect. J. Pharmacol. Exp. Ther. 1983, 227:160-166.
39. Shelton K.L. Inhaled toluene vapor as a discriminative stimulus. Behav. Pharmacol. 2007, 18:219-229.
40. Shelton K.L. Discriminative stimulus effects of inhaled 1,1,1-trichloroethane in mice: comparison to other hydrocarbon vapors and volatile anesthetics. Psychopharmacology (Berl.) 2009, 203:431-440.
41. Shelton K.L. Pharmacological characterization of the discriminative stimulus of inhaled 1,1,1-trichloroethane. J. Pharmacol. Exp. Ther. 2010, 333:612-620.
42. Shelton K.L., Balster R.L. Ethanol drug discrimination in rats: substitution with GABA agonists and NMDA antagonists. Behav. Pharmacol. 1994, 5:441-451.
43. Shelton K.L., Balster R.L. Effects of abused inhalants and GABA-positive modulators in dizocilpine discriminating inbred mice. Pharmacol. Biochem. Behav. 2004, 79:219-228.
44. Shelton K.L., Slavova-Hernandez G. Characterization on an inhaled toluene drug discrimination in mice: effect of exposure conditions and route of administration. Phamacol. Biochem. Behav. 2009, 92:614-620.
45. Shelton K.L., Nicholson K.L. GABA(A) positive modulator and NMDA antagonist-like discriminative stimulus effects of isoflurane vapor in mice. Psychopharmacology (Berl.) 2010, 212:559-569.
46. Substance Abuse and Mental Health Services Administration, 2010. Results From the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings. Office of Applied Studies, NSDUH Series H-38A. HHS Publication SMA 10-4586. Rockville, MD.
47. Tallarida R.J., Murray R.B. Manual of Pharmacological Calculations with Computer Programs 1986, Springer-Verlag, Berlin. 2nd ed.
48. Troutman W.G. Additional deaths associated with the intentional inhalation of typewriter correction fluid. Vet. Hum. Toxicol. 1988, 30:130-132.
49. Willetts J., Bobelis D.J., Balster R.L. Drug discrimination based on the competitive N-methyl-d-aspartate antagonist, NPC 12626. Psychopharmacology (Berl.) 1989, 99:458-462.